Your browser doesn't support javascript.
loading
Skeletal-related events and mortality among older men with advanced prostate cancer.
Onukwugha, Eberechukwu; Yong, Candice; Mullins, C Daniel; Seal, Brian; McNally, Diane; Hussain, Arif.
Afiliação
  • Onukwugha E; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA. Electronic address: eonukwug@rx.umaryland.edu.
  • Yong C; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA.
  • Mullins CD; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA.
  • Seal B; Bayer HealthCare Pharmaceuticals, Inc., USA.
  • McNally D; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA.
  • Hussain A; University of Maryland School of Medicine, 685 West Baltimore Street, Baltimore, MD 21201, USA; Veterans Affairs Medical Center, Baltimore, MD 21201, USA.
J Geriatr Oncol ; 5(3): 281-9, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24726866
OBJECTIVE: Skeletal-related events (SREs) are defined as a cluster of events including clinical diagnoses and treatment. Using claims data, the burden of SREs as a group has been reported among patients with cancer. We investigate the mortality impact of subcomponents of SREs, a topic that has received limited attention among older men. MATERIALS AND METHODS: We analyzed prostate cancer (PCa) and all-cause mortality among men diagnosed with metastatic PCa from 2000 to 2007 using Surveillance, Epidemiology, and End Results data linked with 1999-2009 Medicare data. We created three measures of pathological fracture (PF), spinal cord compression (SCC), and bone surgery (BS) that differed in the use of claims-based bone metastasis information. We reported covariate-adjusted hazard ratios (HRs) using the full sample and a propensity score-matched sample (PSMS). RESULTS: Application of inclusion/exclusion criteria resulted in 7062 men in the full sample (1776 in the PSMS). PCa-specific (all-cause mortality) was 54% (80%) at a median follow-up of 609days. SRE prevalence ranged from 9.7% to 17.1% across the measures. In a PCa mortality model, the HR associated with an SRE ranged from 1.07 (0.98-1.16) to 1.31 (1.18-1.45). The HRs for SCC and PF were statistically significant and positively associated with PCa-specific mortality. The results for BS depended on the measure. Results for SCC and BS, but not for PF, were preserved using a PSMS. CONCLUSIONS: The relationship between SREs and mortality among older men with metastatic PCa was driven by SCC and depended on the definition used to measure SREs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Ósseas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2014 Tipo de documento: Article País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Ósseas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2014 Tipo de documento: Article País de publicação: Holanda